TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 242 filers reported holding TG THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $362,832 | -64.2% | 43,401 | +6.5% | 0.00% | -66.7% |
| Q2 2023 | $1,012,652 | +74.6% | 40,767 | +4.1% | 0.01% | +80.0% |
| Q1 2023 | $579,897 | +146.0% | 39,174 | +85.9% | 0.01% | +150.0% |
| Q4 2022 | $235,721 | +112.4% | 21,069 | -1.2% | 0.00% | 0.0% |
| Q3 2022 | $111,000 | +40.5% | 21,324 | +14.5% | 0.00% | +100.0% |
| Q2 2022 | $79,000 | -52.1% | 18,624 | +7.6% | 0.00% | -50.0% |
| Q1 2022 | $165,000 | -60.0% | 17,313 | -20.1% | 0.00% | -66.7% |
| Q4 2021 | $412,000 | -34.0% | 21,659 | +15.5% | 0.01% | -40.0% |
| Q3 2021 | $624,000 | +28.7% | 18,745 | +50.0% | 0.01% | +25.0% |
| Q2 2021 | $485,000 | – | 12,499 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 5,229,619 | $74,261,000 | 3.55% |
| RA Capital Management | 2,472,344 | $35,107,000 | 2.69% |
| SENZAR ASSET MANAGEMENT, LLC | 475,918 | $6,758,000 | 2.13% |
| BRIDGER MANAGEMENT, LLC | 2,373,920 | $33,710,000 | 2.04% |
| Opaleye Management Inc. | 274,200 | $3,893,000 | 1.11% |
| Virtus ETF Advisers LLC | 89,920 | $1,277,000 | 1.11% |
| Eversept Partners, LP | 150,000 | $2,130,000 | 0.99% |
| Ghost Tree Capital, LLC | 300,000 | $4,260,000 | 0.86% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $710,000 | 0.42% |
| HIGHLAND CAPITAL MANAGEMENT LP | 464,391 | $6,595,000 | 0.34% |